Headlands Technologies LLC trimmed its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 93.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 871 shares of the company's stock after selling 13,069 shares during the quarter. Headlands Technologies LLC's holdings in Colgate-Palmolive were worth $79,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in CL. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $32,000. Finally, Wintrust Investments LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $33,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Up 2.4 %
Colgate-Palmolive stock traded up $2.19 during trading on Friday, reaching $93.99. The stock had a trading volume of 5,664,216 shares, compared to its average volume of 4,587,585. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The stock has a market cap of $76.24 billion, a PE ratio of 26.70, a P/E/G ratio of 4.20 and a beta of 0.40. The business has a 50 day moving average price of $90.48 and a 200 day moving average price of $92.65.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company posted $0.87 earnings per share. On average, analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive declared that its Board of Directors has approved a stock buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio (DPR) is 59.09%.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on CL shares. Piper Sandler reduced their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Barclays reduced their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Friday. Finally, Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $101.67.
Get Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
